Show simple item record

dc.contributor.authorSchlesinger, Daphne E.
dc.contributor.authorStultz, Collin M
dc.date.accessioned2021-09-20T17:29:52Z
dc.date.available2021-09-20T17:29:52Z
dc.date.issued2020-06
dc.identifier.issn1092-8464
dc.identifier.issn1534-3189
dc.identifier.urihttps://hdl.handle.net/1721.1/131714
dc.description.abstractPurpose of review Although deep learning represents an exciting platform for the development of risk stratification models, it is challenging to evaluate these models beyond simple statistical measures of success, which do not always provide insight into a model’s clinical utility. Here we propose a framework for evaluating deep learning models and discuss a number of interesting applications in light of these rubrics. Recent findings Data scientists and clinicians alike have applied a variety of deep learning techniques to both medical images and structured electronic medical record data. In many cases, these methods have resulted in risk stratification models that have improved discriminatory ability relative to more straightforward methods. Nevertheless, in many instances, it remains unclear how useful the resulting models are to practicing clinicians. Summary To be useful, deep learning models for cardiovascular risk stratification must not only be accurate but they must also provide insight into when they are likely to yield inaccurate results and be explainable in the sense that health care providers can understand why the model arrives at a particular result. These additional criteria help to ensure that the model can be faithfully applied to the demographic for which it is most accurate.en_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionofhttp://dx.doi.org/10.1007/s11936-020-00814-0en_US
dc.rightsCreative Commons Attributionen_US
dc.sourceSpringer USen_US
dc.titleDeep Learning for Cardiovascular Risk Stratificationen_US
dc.typeArticleen_US
dc.identifier.citationSchlesinger, Daphne E. and C.M. Stultz. "Deep Learning for Cardiovascular Risk Stratification." Current Treatment Options in Cardiovascular Medicine 22, 8 (June 2020): 15 © 2020 Springer Natureen_US
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Scienceen_US
dc.contributor.departmentMassachusetts Institute of Technology. Research Laboratory of Electronicsen_US
dc.contributor.departmentMassachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratoryen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Electrical Engineering and Computer Scienceen_US
dc.relation.journalCurrent Treatment Options in Cardiovascular Medicineen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-06-26T13:31:02Z
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dspace.embargo.termsN
dspace.date.submission2020-06-26T13:31:02Z
mit.journal.volume22en_US
mit.journal.issue8en_US
mit.metadata.statusAuthority Work and Publication Information Needed


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record